ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,972,888 | +11.0% | 10,115 | -12.1% | 1.18% | +22.9% |
| Q2 2023 | $4,480,175 | -10.1% | 11,504 | -14.0% | 0.96% | -12.8% |
| Q1 2023 | $4,985,426 | -14.5% | 13,381 | -13.8% | 1.10% | -15.9% |
| Q4 2022 | $5,833,012 | -3.3% | 15,522 | -9.2% | 1.31% | -6.0% |
| Q3 2022 | $6,034,000 | -14.6% | 17,088 | -8.2% | 1.39% | -6.2% |
| Q2 2022 | $7,062,000 | +6.0% | 18,624 | -11.9% | 1.49% | +48.7% |
| Q1 2022 | $6,663,000 | -10.0% | 21,145 | +0.1% | 1.00% | +3.4% |
| Q4 2021 | $7,404,000 | – | 21,125 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |